Deerfield Management Company, L.P. (Series C) Invitae Corp Transaction History

Deerfield Management Company, L.P. (Series C)

$5.38 Billion
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.2 - $2.73 $11.1 Million - $25.3 Million	9,274,707 New	9,274,707 $12.5 Million
Q3 2019 Nov 14, 2019	SELL	$18.85 - $27.5 $18.8 Million - $27.4 Million	-995,312 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$17.37 - $26.27 $10.1 Million - $15.3 Million	582,112 Added 140.88%	995,312 $23.4 Million
Q1 2019 May 15, 2019	SELL	$10.65 - $25.75 $2.93 Million - $7.08 Million	-274,862 Reduced 39.95%	413,200 $9.68 Million
Q3 2018 Nov 14, 2018	SELL	$7.54 - $18.31 $9.15 Million - $22.2 Million	-1,213,726 Reduced 63.82%	688,062 $11.5 Million
Q1 2018 May 15, 2018	BUY	$4.69 - $10.05 $838,515 - $1.8 Million	178,788 Added 10.38%	1,901,788 $8.92 Million
Q4 2017 Feb 14, 2018	BUY	$7.86 - $9.99 $6.47 Million - $8.22 Million	823,000 Added 91.44%	1,723,000 $15.6 Million
Q3 2017 Nov 13, 2017	BUY	$8.89 - $10.4 $8 Million - $9.36 Million	900,000	900,000 $8.43 Million

Others Institutions Holding NVTA

# of Institutions

Shares Held

1.92M

Call Options Held

Put Options Held

View Full List

About Invitae Corp

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

More about NVTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Account